Cite
HARVARD Citation
Roade, L. et al. (2020). Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide. Digestive and liver disease. 52 (10), pp. 1164-1169. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Roade, L. et al. (2020). Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide. Digestive and liver disease. 52 (10), pp. 1164-1169. [Online].